INTREPID POTASH INC (IPI) Stock Fundamental Analysis
NYSE:IPI - New York Stock Exchange, Inc. - US46121Y2019 - Common Stock - Currency: USD
Overall IPI gets a fundamental rating of 3 out of 10. We evaluated IPI against 85 industry peers in the Chemicals industry. IPI has a great financial health rating, but its profitability evaluates not so good. IPI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
IPI had positive earnings in the past year.
IPI had a positive operating cash flow in the past year.
In multiple years IPI reported negative net income over the last 5 years.
IPI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IPI's Return On Assets of -34.11% is on the low side compared to the rest of the industry. IPI is outperformed by 88.24% of its industry peers.
With a Return On Equity value of -42.78%, IPI is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
IPI has a Return On Invested Capital of 0.13%. This is in the lower half of the industry: IPI underperforms 77.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROIC | 0.13% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 0.35%, IPI is not doing good in the industry: 77.65% of the companies in the same industry are doing better.
IPI has a Gross Margin of 13.64%. This is in the lower half of the industry: IPI underperforms 76.47% of its industry peers.
In the last couple of years the Gross Margin of IPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IPI is destroying value.
The number of shares outstanding for IPI has been increased compared to 1 year ago.
Compared to 5 years ago, IPI has less shares outstanding
Compared to 1 year ago, IPI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.84 indicates that IPI is not a great score, but indicates only limited risk for bankruptcy at the moment.
IPI has a Altman-Z score of 2.84. This is in the better half of the industry: IPI outperforms 78.82% of its industry peers.
The Debt to FCF ratio of IPI is 0.25, which is an excellent value as it means it would take IPI, only 0.25 years of fcf income to pay off all of its debts.
IPI has a better Debt to FCF ratio (0.25) than 97.65% of its industry peers.
IPI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
IPI's Debt to Equity ratio of 0.00 is amongst the best of the industry. IPI outperforms 96.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Altman-Z | 2.84 |
ROIC/WACC0.01
WACC9.15%
2.3 Liquidity
IPI has a Current Ratio of 5.17. This indicates that IPI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.17, IPI belongs to the top of the industry, outperforming 92.94% of the companies in the same industry.
A Quick Ratio of 2.62 indicates that IPI has no problem at all paying its short term obligations.
IPI has a Quick ratio of 2.62. This is amongst the best in the industry. IPI outperforms 87.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 |
3. Growth
3.1 Past
IPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.67%, which is quite impressive.
The Revenue has been growing slightly by 0.63% in the past year.
The Revenue has been growing slightly by 2.96% on average over the past years.
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
3.2 Future
The Earnings Per Share is expected to decrease by -4.26% on average over the next years.
The Revenue is expected to decrease by -0.21% on average over the next years.
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 466.13, the valuation of IPI can be described as expensive.
68.24% of the companies in the same industry are cheaper than IPI, based on the Price/Earnings ratio.
IPI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.52.
The Forward Price/Earnings Ratio is negative for IPI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 466.13 | ||
| Fwd PE | N/A |
4.2 Price Multiples
IPI's Enterprise Value to EBITDA ratio is in line with the industry average.
IPI's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 77.91 | ||
| EV/EBITDA | 11.34 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A cheap valuation may be justified as IPI's earnings are expected to decrease with -4.26% in the coming years.
PEG (NY)2.36
PEG (5Y)N/A
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
5. Dividend
5.1 Amount
IPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
37.29
-0.62 (-1.64%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners54.42%
Inst Owner Change4.05%
Ins Owners1.79%
Ins Owner Change-0.71%
Market Cap496.70M
Analysts42.22
Price Target21.42 (-42.56%)
Short Float %3.37%
Short Ratio1.57
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)365.13%
Min EPS beat(2)-142.02%
Max EPS beat(2)872.28%
EPS beat(4)1
Avg EPS beat(4)-141.12%
Min EPS beat(4)-1288.12%
Max EPS beat(4)872.28%
EPS beat(8)1
Avg EPS beat(8)-133.02%
EPS beat(12)1
Avg EPS beat(12)-97.98%
EPS beat(16)3
Avg EPS beat(16)-73.69%
Revenue beat(2)2
Avg Revenue beat(2)13.58%
Min Revenue beat(2)9.74%
Max Revenue beat(2)17.42%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)9.74%
Max Revenue beat(4)28.94%
Revenue beat(8)8
Avg Revenue beat(8)23.01%
Revenue beat(12)11
Avg Revenue beat(12)19.62%
Revenue beat(16)15
Avg Revenue beat(16)18.77%
PT rev (1m)10.53%
PT rev (3m)0%
EPS NQ rev (1m)425%
EPS NQ rev (3m)180.77%
EPS NY rev (1m)434.62%
EPS NY rev (3m)233.85%
Revenue NQ rev (1m)3.98%
Revenue NQ rev (3m)3.16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 466.13 | ||
| Fwd PE | N/A | ||
| P/S | 1.82 | ||
| P/FCF | 77.91 | ||
| P/OCF | 11.86 | ||
| P/B | 1.04 | ||
| P/tB | 1.09 | ||
| EV/EBITDA | 11.34 |
EPS(TTM)0.08
EY0.21%
EPS(NY)-0.44
Fwd EYN/A
FCF(TTM)0.48
FCFY1.28%
OCF(TTM)3.14
OCFY8.43%
SpS20.51
BVpS35.99
TBVpS34.2
PEG (NY)2.36
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -34.11% | ||
| ROE | -42.78% | ||
| ROCE | 0.17% | ||
| ROIC | 0.13% | ||
| ROICexc | 0.15% | ||
| ROICexgc | 0.15% | ||
| OM | 0.35% | ||
| PM (TTM) | N/A | ||
| GM | 13.64% | ||
| FCFM | 2.33% |
ROA(3y)-10.45%
ROA(5y)-0.74%
ROE(3y)-13.33%
ROE(5y)-1.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.91%
GM growth 5Y-10.39%
F-Score5
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.25 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 91.35% | ||
| Cap/Sales | 13% | ||
| Interest Coverage | 2.22 | ||
| Cash Conversion | 105.16% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 2.62 | ||
| Altman-Z | 2.84 |
F-Score5
WACC9.15%
ROIC/WACC0.01
Cap/Depr(3y)154.88%
Cap/Depr(5y)113.05%
Cap/Sales(3y)19.65%
Cap/Sales(5y)14.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%378.57%
EPS Next Y197.63%
EPS Next 2Y0.62%
EPS Next 3Y-4.26%
EPS Next 5YN/A
Revenue 1Y (TTM)0.63%
Revenue growth 3Y-1.96%
Revenue growth 5Y2.96%
Sales Q2Q%23.3%
Revenue Next Year3.33%
Revenue Next 2Y-0.31%
Revenue Next 3Y-0.21%
Revenue Next 5YN/A
EBIT growth 1Y111.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1489.26%
EBIT Next 3Y128.42%
EBIT Next 5YN/A
FCF growth 1Y132.2%
FCF growth 3Y-17.26%
FCF growth 5YN/A
OCF growth 1Y-33.63%
OCF growth 3Y-2.86%
OCF growth 5Y7.97%